Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,436 | 62,260 | 74,867 | 37,878 | 29,356 |
| Marketable Securities | N/A | 41,894 | 53,240 | 34,751 | N/A |
| Receivables | 1,706 | 6,787 | 2,701 | 15,546 | 57 |
| TOTAL | $75,721 | $115,013 | $135,382 | $89,790 | $32,673 |
| Non-Current Assets | |||||
| PPE Net | 22,046 | 19,502 | 5,049 | 4,034 | 2,264 |
| Investments And Advances | 0 | 0 | 0 | 9,922 | 0 |
| Other Non-Current Assets | 7,243 | 6,582 | 910 | 130 | 126 |
| TOTAL | $29,289 | $26,084 | $5,959 | $14,086 | $2,390 |
| Total Assets | $105,010 | $141,097 | $141,341 | $103,876 | $35,063 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,787 | 5,803 | 3,350 | 2,452 | 2,386 |
| Accrued Expenses | 7,731 | 9,944 | 9,114 | 6,170 | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 3,719 |
| TOTAL | $22,145 | $27,003 | $48,076 | $45,775 | $8,380 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,627 | 11,256 | 35,612 | 37,153 | 2,275 |
| Other Non-Current Liabilities | 15,938 | 15,484 | 27 | 37 | 47 |
| TOTAL | $51,838 | $62,742 | $53,330 | $46,579 | $1,456 |
| Total Liabilities | $73,983 | $89,745 | $101,406 | $92,354 | $9,836 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 746 | 690 | 614 | 673 | 538 |
| Common Shares | 56 | 55 | 54 | 45 | 43 |
| Retained earnings | -211,406 | -174,176 | -147,066 | -120,312 | -102,665 |
| Other shareholders' equity | -295 | -1,995 | -2,982 | -4,695 | -1,501 |
| TOTAL | $31,027 | $51,352 | $39,935 | $11,522 | $25,227 |
| Total Liabilities And Equity | $105,010 | $141,097 | $141,341 | $103,876 | $35,063 |